MY146615A - Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome - Google Patents

Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome

Info

Publication number
MY146615A
MY146615A MYPI20094947A MYPI20094947A MY146615A MY 146615 A MY146615 A MY 146615A MY PI20094947 A MYPI20094947 A MY PI20094947A MY PI20094947 A MYPI20094947 A MY PI20094947A MY 146615 A MY146615 A MY 146615A
Authority
MY
Malaysia
Prior art keywords
preventing
heptacyclic compounds
metabolic syndrome
treating diabetes
pharmaceutical uses
Prior art date
Application number
MYPI20094947A
Inventor
Shen Jianhua
Leng Ying
Jiang Hualing
Chen Junhua
Original Assignee
Shanghai Inst Materia Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Inst Materia Medica filed Critical Shanghai Inst Materia Medica
Priority to MYPI20094947A priority Critical patent/MY146615A/en
Publication of MY146615A publication Critical patent/MY146615A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

THE INVENTION DISCLOSES A NEW USE OF A CLASS HEPTACYCLIC COMPOUNDS IN THE PREPARATION OF FORMULATIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND METABOLIC SYNDROMES; THE PRESENT INVENTION ALSO DISCLOSES A NEW CLASS OF HEPTACYCLIC COMPOUNDS; THE PRESENT INVENTION ALSO DISCLOSES A PROCESS FOR PREPARING THE HEPTACYCLIC COMPOUNDS AND A COMPOSITION CONTAINING THE SAME. THE HEPTACYCLIC COMPOUNDS OF THE PRESENT INVENTION CAN BE USED TO EFFECTIVELY PREVENTING OR TREATING DISEASES SUCH AS DIABETES AND METABOLIC SYNDROMES.
MYPI20094947A 2007-05-29 2007-05-29 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome MY146615A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20094947A MY146615A (en) 2007-05-29 2007-05-29 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20094947A MY146615A (en) 2007-05-29 2007-05-29 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome

Publications (1)

Publication Number Publication Date
MY146615A true MY146615A (en) 2012-09-14

Family

ID=48041007

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20094947A MY146615A (en) 2007-05-29 2007-05-29 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome

Country Status (1)

Country Link
MY (1) MY146615A (en)

Similar Documents

Publication Publication Date Title
MX2009012920A (en) Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome.
MY155695A (en) Quinoxalinedione derivatives
UA98804C2 (en) Catecholamine derivatives and pharmaceutical composition based thereon
UA100840C2 (en) Composition for the treatment of viral hepatitis
IN2012DN01233A (en)
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
MX2011006959A (en) Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds.
MX2009012000A (en) Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis.
IL195947A (en) Fused cyclic compounds and pharmaceutical compositions comprising them for use in the prevention and treatment of diabetes
TW200700093A (en) Pharmaceutical composition for the treatment of cancer
GEP20125565B (en) Lactam compounds and their pharmaceutical use
MY150787A (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of prevention of diabetes
EP2571876A4 (en) Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
MY174002A (en) Combination theraphy for the treatment of diabetes
MX2010009022A (en) 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use.
MX2010002278A (en) Antiviral drugs for treatment of arenavirus infection.
IL201189A (en) Fluorinated derivatives of deferiprone for use as iron chelators in the treatment of neurodegenerative diseases, process for their preparation and pharmaceutical compositions comprising them
EP2137175A4 (en) Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
MX2009013501A (en) Piperidine compounds and uses thereof.
MX367131B (en) 3,6-disubstituted xanthylium salts as medicaments.
WO2009062576A8 (en) Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
MX2012000954A (en) Pharmaceutical compositions.
CL2008000982A1 (en) COMPOUNDS DERIVED FROM 5-OXO-ISOXAZOL-CARBOXAMIDA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PROCEDURE OF PRODUCTION OF THE PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PREVENTION OF ATEROSCLEROTIC DISORDERS, OF METABOLISM OF
AU2005238141A8 (en) Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
GB0615105D0 (en) Novel compounds